Steps involved in immortalization and tumorigenesis in human B-lymphoblastoid cell lines transformed by Epstein-Barr virus

Cancer Research

Volumn 64, Issue 10, 2004, Pages 3361-3364

  Sugimoto, Masanobu ^a,c   Tahara, Hidetoshi ^b   Ide, Toshinori ^b   Furuichi, Yasuhiro ^a  

^a GeneCere Research Institute   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

^c GeneCare Research Institute   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AGAROSE; EPSTEIN BARR VIRUS PROTEIN; PROTEIN P16; PROTEIN P53; RETINOBLASTOMA PROTEIN; TELOMERASE; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANEUPLOIDY; B LYMPHOBLAST; BURKITT LYMPHOMA; CARCINOGENESIS; CELL IMMORTALIZATION; DIPLOIDY; DOWN REGULATION; ENZYME ACTIVITY; EPSTEIN BARR VIRUS; GENE MUTATION; HUMAN; HUMAN CELL; KARYOTYPE; LYMPHOCYTE PROLIFERATION; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; REVIEW; TELOMERE;

ANIMALS; B-LYMPHOCYTES; CELL TRANSFORMATION, VIRAL; HERPESVIRUS 4, HUMAN; HUMANS;

EID: 2442679371     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-0079     Document Type: Review

References (45)

1. Epstein MA, Achong BG, Barr YM. Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet 1964;15:702-3.
2. Epstein MA. Historical background. Philos Trans R Soc Lond B Biol Sci 2001;356:413-20.
3. Niedobitek G, Meru N, Delecluse HJ. Epstein-Barr virus infection and human malignancies. Int J Exp Pathol 2001;82:149-70.
4. Kawa K. Epstein-Barr virus-associated diseases in humans. Int J Hematol 2000;71:108-17.
5. Farrell PJ. Epstein-Barr virus immortalizing genes. Trends Microbiol 1995;3:105-9.
6. Nilsson, K. The nature of lymphoid cell lines and their relationship to the virus. Berlin, Germany: Springer-Verlag, 1979.
7. Miller, G. Epstein-Barr virus biology, pathogenesis and medical aspects. In: Fields BN, Knipe KM, editors. Virology. New York: Raven Press, 1990. p. 1921-58
8. Henle W, Diehl V, Kohn G, Zur Hausen H, Henle G. Herpes-type virus and chromosome marker in normal leukocytes after growth with irradiated Burkitt cells. Science 1967;157:1064-5.
9. Miller G, Enders JF, Lisco H, Kohn HI. Establishment of lines from normal human blood leukocytes by co-cultivation with a leukocyte line derived from a leukemic child. Proc Soc Exp Biol Med 1969;132:247-52.
10. Gerber P, Lucas S, Nonoyama M, Perlin E, Goldstein LI. Oral excretion of Epstein-Barr virus by healthy subjects and patients with infectious mononucleosis. Lancet 1972;2:988-9.
11. Aman P, Ehlin-Henriksson B, Klein G. Epstein-Barr virus susceptibility of normal human B lymphocyte populations. J Exp Med 1984;159:208-20.
12. Miller G, Lipman M. Release of infectious Epstein-Barr virus by transformed marmoset leukocytes. Proc Natl Acad Sci USA 1973;70:190-4.
13. Nilsson K. Human B-lymphoid cell lines. Hum Cell 1992;5:25-41.
14. Counter CM, Avilion AA, LeFeuvre CE, et al. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J 1992;11:1921-9.
15. Counter CM, Botelho FM, Wang P, Harley CB, Bacchetti S. Stabilization of short telomeres and telomerase activity accompany immortalization of Epstein-Barr virus-transformed human B lymphocytes. J Virol 1994;68:3410-4.
16. Sugimoto M, Ide T, Goto M, Furuichi Y. Reconsideration of senescence, immortalization and telomere maintenance of Epstein-Barr virus-transformed human B-lymphoblastoid cell lines. Mech Ageing Dev 1999;107:51-60.
17. Sugimoto M, Ide T, Goto M, Furuichi Y. Incorrect use of "immortalization" for B-lymphoblastoid cell lines transformed by Epstein-Barr virus. J Virol 1999;73:9690-1.
18. Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994;266:2011-5.
19. Sugden B, Mark W. Clonal transformation of adult human leukocytes by Epstein-Barr virus. J Virol 1977;23:503-8.
20. Tahara H, Tokutake Y, Maeda S, et al. Abnormal telomere dynamics of B-lymphoblastoid cell strains from Werner's syndrome patients transformed by Epstein-Barr virus. Oncogene 1997;15:1911-20.
21. Kataoka H, Tahara H, Watanabe T, et al. Immortalization of immunologically committed Epstein-Barr virus-transformed human B-lymphoblastoid cell lines accompanied by a strong telomerase activity. Differentiation 1997;62:203-11.
22. Okubo M, Tsurukubo Y, Higaki T, et al. Clonal chromosomal aberrations accompanied by strong telomerase activity in immortalization of human B-lymphoblastoid cell lines transformed by Epstein-Barr virus. Cancer Genet Cytogenet 2001;129:30-4.
23. Takahashi T, Kawabe T, Okazaki Y, et al. In vitro establishment of tumorigenic human B-lymphoblastoid cell lines transformed by Epstein-Barr virus. DNA Cell Biol 2003;22:727-35.
24. Yu CE, Oshima J, Fu YH, et al. Positional cloning of the Werner's syndrome gene. Science 1996;272:258-62.
25. Sugimoto M, Tahara H, Okubo M, et al. WRN gene and other genetic factors affecting immortalization of human B-lymphoblastoid cell lines transformed by Epstein-Barr virus. Cancer Genet Cytogenet. In press 2004.
26. Salk D, Bryant E, Hoehn H, Johnston P, Martin GM. Growth characteristics of Werner syndrome cells in vitro. Adv Exp Med Biol 1985;190:305-11.
27. Kawabe T, Tsuyama N, Kitao S, et al. Differential regulation of human RecQ family helicases in cell transformation and cell cycle. Oncogene 2000;19:4764-72.
28. Shiratori M, Sakamoto S, Suzuki N, et al. Detection by epitope-defined monoclonal antibodies of Werner DNA helicases in the nucleoplasm and their upregulation by cell transformation and immortalization. J Cell Biol 1999;144:1-9.
29. Schulz VP, Zakian VA, Ogburn CE, et al. Accelerated loss of telomeric repeats may not explain accelerated replicative decline of Werner syndrome cells. Hum Genet 1996;97:750-4.
30. Opresko PL, von Kobbe C, Laine JP, Harrigan J, Hickson ID, Bohr VA. Telomere-binding protein TRF2 binds to and stimulates the Werner and Bloom syndrome helicases. J Biol Chem 2002;277:41110-9.
31. Ohsugi I, Imamura O, Satoh M, et al. Overexpression of mRNAs of TGFβ-1 and related genes in fibroblasts of Werner syndrome patients. Mech Ageing Dev 2000;115:189-98.
32. Bryan TM, Reddel RR. Telomere dynamics and telomerase activity in in vitro immortalised human cells. Eur J Cancer 1997;33:767-73.
33. Hayflick L, Moorhead P. The serial cultivation of human diploid cell strains. Exp Cell Res 1961;25:586-621.
34. Shay JW, West MD, Wright WE. Re-expression of senescent markers in deinduced reversibly immortalized cells. Exp Gerontol 1992;27:477-92.
35. Satoh M, Yasuda T, Higaki T, et al. Innate apoptosis of human B lymphoblasts transformed by Epstein-Barr virus: modulation by cellular immortalization and senescence. Cell Struct Funct 2003;28:61-70.
36. Okada M, Goto M, Furuichi Y, Sugimoto M. Differential effects of cytotoxic drugs on mortal and immortalized B-lymphoblastoid cell lines from normal and Werner's syndrome patients. Biol Pharm Bull 1998;21:235-9.
37. Sugimoto M, Noda K, Furuichi Y. Apoptosis of human B lymphoblastoid cell lines transformed by Epstein-Barr virus: modulation by cellular immortalization and senescence (in Japanese). Saibou 2003;35:564-7.
38. Nilsson K, Giovanella BC, Stehlin JS, Klein G. Tumorigenicity of human hematopoietic cell lines in athymic nude mice. Int J Cancer 1977;19:337-44.
39. Christofinis GJ. Chromosome and transplantation results of a human leukocyte cell line derived from a healthy individual. Cancer 1969;24:649-51.
40. Imamura T, Huang CC, Minowada J, Moore GE. Heterologous transplantation of human hematopoietic cell lines. Cancer 1970;25:1320-31.
41. Hammerschmidt W, Sugden B. Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes. Nature 1989;340:393-7.
42. Cohen JI, Wang F, Kieff E. Epstein-Barr virus nuclear protein 2 mutations define essential domains for transformation and transactivation. J Virol 1991;65:2545-54.
43. Kaye KM, Izumi KM, Kieff E. Epstein-Barr virus latent membrane protein I is essential for B-lymphocyte growth transformation. Proc Natl Acad Sci USA 1993;90:9150-4.
44. Tomkinson B, Robertson E, Kieff E. Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation. J Virol 1993;67:2014-25.
45. Kilger E, Kieser A, Baumann M, Hammerschmidt W. Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor. EMBO J 1998;17:1700-9.